“Gengnian Ningxin Granules” for the treatment of perimenopausal syndrome:a randomized, double-blind, placebo-controlled clinical trial
|更新时间:2022-08-31
|
“Gengnian Ningxin Granules” for the treatment of perimenopausal syndrome:a randomized, double-blind, placebo-controlled clinical trial
Shanghai Journal of Traditional Chinese MedicineVol. 49, Issue 3, Pages: 35-37(2015)
作者机构:
1. 上海中医药大学附属龙华医院妇科,上海,200032
作者简介:
基金信息:
DOI:
CLC:
扫 描 看 全 文
NI Shuang, LI Ji, ZHANG Li, et al. “Gengnian Ningxin Granules” for the treatment of perimenopausal syndrome:a randomized, double-blind, placebo-controlled clinical trial. [J]. Shanghai Journal of Traditional Chinese Medicine 49(3):35-37(2015)
DOI:
NI Shuang, LI Ji, ZHANG Li, et al. “Gengnian Ningxin Granules” for the treatment of perimenopausal syndrome:a randomized, double-blind, placebo-controlled clinical trial. [J]. Shanghai Journal of Traditional Chinese Medicine 49(3):35-37(2015)DOI:
“Gengnian Ningxin Granules” for the treatment of perimenopausal syndrome:a randomized, double-blind, placebo-controlled clinical trial
Objective: To observe the clinical efficacy of “Gengnian Ningxin Granules” in treating perimenopausal syndrome. Methods Sixty cases with perimenopausal syndrome were randomized into treatment group and control group, with 30 cases in each group. Treatment group was treated with “Gengnian Ningxin Granules”, and the control group was treated with placebo, with the course of 2 months. The modified Kupperman index, hot flashes times and levels of sex hormones (FSH, LH, E,2,) were observed. Results: ① Non-shedding case during the period of the clinical trial. All the 60 cases completed the study. ② In both groups, there was significant difference in KI score between before and after the treatment (P<0.05); after treatment, there was significant difference in KI score between the two groups (P<0.05). ③ In both groups, there was significant difference in hot flashes times between before and after the treatment (P<0.05); after treatment, there was significant difference between the two groups (P<0.05). ④ In both groups, no significant difference was found in the levels of sex hormones (E,2, FSH, LH) between before and after the treatment (P>0.05); after treatment, no significant difference was found in the levels of E,2, FSH and LH between the two groups (P>0.05). Conclusion: “Gengnian Ningxin Granules” is effective to improve the clinical symptoms in patients with perimenopausal syndrome. Its mechanism may be not association with the improvement of estrogen level.
关键词
围绝经期综合征更年宁心颗粒清心平肝法安慰剂
Keywords
perimenopausal syndrome“Gengnian Ningxin Granules”clearing heart and soothing liver methodplacebo
Study on distribution of related symptoms and TCM syndromes in women with perimenopausal syndrome
Experience of treating perimenopausal syndrome with classical prescriptions
Yangxue Ruanjian capsule in treatment of knee osteoarthritis: a randomized, double-blind and placebo-controlled clinical trial
Efficacy observation on effects of Shexiang Tongxin Dropping Pill on myocardial reperfusion in STEMI patients after PCI surgery
Clinical study of Hezhong Jianpi Decoction in the treatment of gastroesophageal reflux disease:A random, double-blind and double-dummy trial
Related Author
No data
Related Institution
International Peace Maternity and Child Health Hospital of China Welfare Institute
Shanghai Jinshan Tinglin Hospital
Department of Traditional Chinese Medicine, Jiangyin Hospital Affiliated to Southeast University
Shi’s Traumatology Medical Center, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Institute of Traumatology & Orthopedics, Shanghai Academy of Traditional Chinese Medicine
Department of Cardiology,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine